Researchers at Keio University found that matrix metalloproteinases improve wound healing in mice, while a complement inhibitor FUT-175 delays autoimmune disease onset. Additionally, a new target for tumor angiogenesis inhibition and bone morphogenic protein-7 (BMP-7) have been identified as potential therapies for liver high blood pre...
A diet high in omega-3 fatty acids has been found to protect against a variety of diseases, including age-related macular degeneration. The study suggests that a diet enriched in EPA and DHA can ameliorate the progression of retinal lesions in a mouse model of AMD.
Researchers have discovered a new gene fusion, NDRG1-ERG, that produces a protein potentially targeted by drug therapies. This finding may improve prostate cancer testing and treatment options.
A recent study found that transplanted neurons develop disease-like pathology in Huntington's patients, raising concerns about the therapeutic potential of cell transplantation therapy. The research suggests new mechanisms involved in the development of the disease and offers a new direction for developing novel therapeutic strategies.
A new procedure called CESA combines endovascular and surgical approaches to treat high-risk aortic aneurysms. The technique has shown excellent results in the first 20 high-risk patients with complex aortic pathology treated with CESA, with a cumulative survival rate of 76% at two years.
Kansas State University researchers developed online teaching modules addressing epidemiology and statistics, accessible to over 30,000 international students. The modules help train plant pathologists in developing countries, overcoming software and language barriers.
Researchers found significant differences in salivary bacteria populations between overweight women and non-overweight women, with a single species Selenomanas noxia linked to over 98% of cases. The study suggests oral bacteria may be related to obesity pathology.
Dr. Brian Shaw will receive the 2009 Alexopoulos Prize for his outstanding contributions to plant pathology research, as recognized by the Mycological Society of America. Shaw has authored 17 research papers in 12 years and is jointly appointed with Texas AgriLife Research.
Dr. Herman Scholthof, a renowned plant pathology expert, has been awarded the 2009 American Phytopathological Society Fellowship for his distinguished contributions to the field. He is recognized for his notable work in plant pathology and microbiology at Texas A&M University.
A new study from Stanford University School of Medicine finds that hair sheep blood is a perfect substitute for horse or sheep blood in microbiology tests, reducing costs and improving diagnosis in the developing world. The researchers also discovered that collecting blood in donation bags eliminates the need for defibrination, making ...
Dr. Keri Smith has received a Career Development Award from the National Hemophilia Foundation to develop a therapy for people with Hemophilia A. Her approach involves altering chemical signals produced by T cells that trigger immune responses, making individuals more receptive to replacement Factor VIII.
A study published in Science Express demonstrates the first definitive link between mutations in the DICER1 gene and cancer. Children with pleuropulmonary blastoma carried a mutation in one of their two DICER1 gene copies, which may disrupt normal lung development and communication.
Scientists have made significant discoveries in the fight against muscular dystrophy, identifying a potential gene therapy approach to overexpress Galgt2 protein. In another breakthrough, researchers have identified a stromal marker for breast cancer progression, highlighting the importance of examining stroma PDGF receptor expression ...
A recent study suggests that gastrin is an essential cofactor for Helicobacter-associated gastric corpus carcinogenesis in mice. High levels of gastrin lead to the development of stomach cancer, while absence of gastrin increases tumor numbers in the gastric antrum.
Researchers at Baylor College of Medicine discovered changes in 1,141 genes that induce the formation of new structures such as blood vessels and nerves in prostate cancer patients. These gene changes may explain why men with reactive stroma face a more aggressive disease.
A recent study has identified a specific neurochemical abnormality in adults with primary insomnia, providing new insights into the condition's pathology. GABA levels were found to be reduced by nearly 30% in individuals with primary insomnia for more than six months.
Researchers discover halofuginone, a compound from traditional Chinese medicine, inhibits Th17 cells and reduces disease pathology in mouse model of autoimmunity. Halofuginone may offer a new treatment option for autoimmune disorders with potential for oral administration.
Researchers at Natura Therapeutics and the University of South Florida are studying the green tea compound TeaMem, which may block a key process in Alzheimer's development. The NIH grant will investigate TeaMem's role in preventing AD pathology and cognitive impairment.
A study has identified a breast cancer gene called AGTR1 that is overexpressed in up to 20% of breast cancers and can be blocked by the blood pressure drug losartan. The researchers found that treatment with losartan shrunk tumors by 30% in mice, suggesting a potential new treatment option for women with AGTR1-positive breast tumors.
Researchers found that almost all HIV virus was packed into macrophages in diseased cells, which are immune cells that 'eat' invading disease agents. This discovery could lead to new treatments by targeting these infected macrophages.
Researchers found that Mycobacterium tuberculosis evades the immune response by promoting regulatory T cells, which suppress the host response. This compartmentalization leads to chronic disease rather than complete eradication of the infection.
Two studies in the American Journal of Pathology demonstrate stromal caveolin-1 as a prognostic marker for breast cancer progression, correlating with reduced metastasis levels. Additionally, researchers have identified novel biomarkers for chronic kidney disease progression, predicting progressive renal fibrosis and glomerular filtrat...
Researchers have found that RAG-1 mediated cleavage occurs on one allele at a time during V(D)J recombination, ensuring allelic exclusion. This process is crucial in preventing translocations, a common underlying mechanism for leukemias and lymphomas.
Researchers at Cancer Research UK have developed a way to regulate viral activity in cancer cells while minimizing its impact on healthy tissues. By introducing microRNA molecules, they can 'turn off' the virus in vulnerable areas, making it a promising approach for improved cancer treatments and vaccines.
Researchers found that only 61.9% of patients assigned a billing diagnosis code for Barrett's esophagus actually had the condition after manual record review. A pathologic diagnosis was highly likely to be reproduced by separate reviews, but electronic coding confirmed only 61.9% of cases.
Researchers used magnetization transfer imaging to visualize alterations in cerebral architecture of Tourette's patients and found correlations with symptom severity. They identified changes in the frontal lobe that may be responsible for the syndrome's pathology.
Researchers have identified a new prognostic factor in breast cancer patients, predicting early disease recurrence, metastasis, and patient survival. The absence of caveolin-1 in the stroma is strongly associated with more aggressive disease and reduced progression-free survival.
A study published in the Journal of Cell Biology reveals that a mutated Alzheimer's-related protein called presenilin helps form and maintain nerve cell connections. The findings suggest that failing nerve transmission might be an early step in the disease's pathology.
Parkinson's disease is characterized by selective loss of dopamine neurons in the substantia nigra, with elevated cytosolic dopamine and calcium levels contributing to cell death. Genetic and environmental 'hits' are required for PD pathology, suggesting multiple therapeutic targets should be considered
Researchers found high osteopontin levels in patients with interstitial lung disease and healthy smokers, while healthy non-smokers produced no osteopontin. Osteopontin expression could be stimulated by nicotine treatment, leading to immune cell recruitment and symptoms similar to smoking-related lung diseases.
Notch1 contributes to lung fibrosis by increasing myofibroblasts, while SOCS-1 inhibits prostate cancer growth. TIP30 prevents lung cancer metastasis, and SPARC accelerates kidney disease progression. These findings highlight potential new therapeutic targets.
Researchers at Johns Hopkins Medicine tracked how prostate cancer began in 33 men, finding a set of genetic defects in a single cell that differ for each person's cancer. The study suggests that common genetic patterns across metastatic sites indicate a single cell source.
A novel gene fusion, SLC45A3-ELK4, is highly expressed in prostate cancers and detectable in urine. This biomarker may help distinguish clinically significant from indolent disease.
Researchers are racing against time to find ways to combat the wheat curl mite, a nemesis of the region's wheat crop. The mites are vectored by three viruses: wheat streak mosaic virus, wheat mosaic virus, and Triticum mosaic virus, with Texas being the hot spot for all three.
Researchers identify TMEM density as key to predicting distant organ metastasis in breast cancer. The new marker could enable custom-tailored therapies and prevent over- or under-treatment.
Researchers at the University of Tokyo identified a novel biomarker to monitor acute kidney injury, while a study found that the unfolded protein response contributes to nerve cell death in Alzheimer's Disease. Additionally, a bacterial toxin disrupts intestinal epithelial barrier function, leading to systemic infection.
Researchers track autoimmune disease development with bioluminescent imaging of NF-κB activation, revealing pathology in multiple organ systems. Early detection is critical for assessing new treatments and preventing disease progression.
Researchers at McMaster University are launching Canada's first tuberculosis (TB) vaccine clinical trial with a vaccine designed, manufactured and tested within the university. The phase 1 clinical trial will evaluate the safety of the new vaccine and assess immune responses in healthy volunteers.
Dr. Cun-Yu Wang is recognized for his groundbreaking research in cancer therapy and oral health, with a focus on molecular signaling, inflammation, and adult human stem cells. He joins an elite group of scientists honored by IADR for their contributions to advancing oral health knowledge worldwide.
A team of Columbia University researchers has identified a new investigational therapy for bladder cancer, inhibiting the mTOR signaling pathway with rapamycin. The discovery demonstrates that p53 and PTEN tumor suppressor genes are inactivated in invasive bladder cancer.
Researchers developed a new immunohistochemical test that accurately diagnoses ARVC, a condition characterized by muscle cell replacement with fatty deposits and fibrosis. The test has the potential to identify patients at risk of sudden death and exclude other causes of arrhythmias.
Researchers identified proepithelin as a protein that encourages cell growth and migration in prostate cancer cells, especially androgen-independent ones. Proepithelin overexpression may serve as a clinical marker for prostate cancer diagnosis and a therapeutic target.
Research suggests that lowering cholesterol levels can block the growth of prostate tumors and reduce cancer incidence. Ezetimibe, a cholesterol-lowering drug, has been shown to inhibit tumor angiogenesis, promoting less aggressive tumors.
Researchers found that HAART contributes to pulmonary hypertension in HIV-infected patients by impairing blood vessel-lining endothelial cell function. A novel treatment for chronic hypoxic pulmonary hypertension (PHTN) involves neprilysin, which protects against PHTN by regulating neural signaling molecules.
A panel of small molecules, including sarcosine, has been identified as potential markers for aggressive prostate cancer. Sarcosine was found in higher levels in advanced prostate cancer samples and was a better indicator than traditional PSA test.
Researchers developed a 50-gene set to identify the four known types of breast cancer, allowing for personalized treatment. The test was found to be highly sensitive and predictive for chemotherapy response, particularly for poor-prognosis tumor types.
New rodent findings show that chronic drinking causes more injury to the liver than acute or binge drinking, with persistent gene-expression changes and deleterious conditioning. This research highlights the importance of daily, excessive drinking in programming the liver to become dependent on alcohol.
Two studies identified a novel biomarker for metastatic bladder cancer and discovered stem cell factor's role in airway remodeling in asthma. Additionally, researchers found that Staphlococcus aureus beta-toxin causes lung injury in pneumonia, while rosiglitazone may reduce the severity of scleroderma.
Research found that inflammation weakens collagen caps in atherosclerotic plaques, making them more prone to rupture. The study identifies lysyl-oxidase as a potential target for preventing plaque rupture and thrombosis.
Researchers found that mice lacking Smad3 are acutely sensitive to bacterially-induced inflammation and cancer. Chronic inflammation stimulates cancer development.
Kansas State University is receiving a $1 million grant from the US Department of Agriculture to study the wheat blast fungus, a pathogen that has become a serious threat in Brazil. The researchers will sequence the fungus's genome and screen Kansas wheat varieties for resistance to the disease.
Researchers at UQ found that speech and language disorders can be validly and reliably assessed over the internet using a telerehabilitation application. This technology holds promise for addressing inequities in access to rehabilitation services, particularly in rural and remote areas.
Researchers at U-M Comprehensive Cancer Center identified recurrent gene fusions that drive certain cancers to develop. New gene sequencing technology enabled quicker and easier detection of these fusions.
Researchers found that laminin-111 restored regenerative capacity in a mouse model for alpha 7 integrin congenital myopathy. The protein promotes muscle cell health and survival by interacting with the extracellular matrix.
Researchers found that irradiation damages fat tissue in mice, reducing its weight and size, and altering its ability to support reconstruction. Additionally, a study on multiple sclerosis found that CXCL1 decreases disease severity by promoting remyelination. A new molecule, FPR-2, has been identified as a potential anti-inflammatory ...
Researchers at St. Jude Children's Research Hospital have developed a gene therapy that alleviates sickle cell disease pathology by introducing a corrective gene into mouse blood cells. The treated mice showed essentially no difference from normal mice, with improved red blood cell production and organ function.
Research suggests melatonin therapy may prevent ocular inflammation in uveitis, reducing symptoms and protecting the blood-ocular barrier. Melatonin treatment has anti-inflammatory effects, potentially benefiting patients with chronic uveitis.
A study found that African-American patients with non-small cell lung cancer have a higher copy number of the epidermal growth factor receptor (EGFR) gene, predicting better long-term outcomes when taking erlotinib and gefitinib. Few EGFR mutations were observed, highlighting the need for more research in this patient population.
Researchers found that blocking Cyclophilin D and developing surrounding mitochondrial targets may be viable strategies for preventing and treating Alzheimer's disease. The study provides new insights into the mechanism underlying amyloid beta-mediated mitochondrial stress, which links to synaptic plasticity and learning/memory.
A team at Montana State University has discovered a fungus that produces diesel fuel, which could offer an alternative to fossil fuels. The fungus, called Gliocladium roseum, can grow in cellulose and produce medium-chain hydrocarbons.